Basics Mineralys Therapeutics, Inc. IPO Date: February 10, 2023 Sector: Healthcare Industry: Biotech Market Cap: $952.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 2.88% Avg Daily Range (30 D): $0.35 | 2.44% Avg Daily Range (90 D): $0.44 | 3.01% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .6M Avg Daily Volume (90 D): .75M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 274 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $1.98M Avg Inst. Trade (90 D): $1.94M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.28M Avg Closing Trade (30 D): $2.33M Avg Closing Trade (90 D): $2.04M Avg Closing Volume: 161.3K     News May 24, 2025 @ 8:30 AM Mineralys Therapeutics Announces Late-Breaking Pre... Source: Mineralys Therapeutics Mar 29, 2025 @ 6:30 PM Mineralys Therapeutics Announces Late-Breaking Dat... Source: N/A Sep 25, 2024 @ 12:00 PM Mineralys Therapeutics Completes Target Enrollment... Source: N/A Sep 16, 2024 @ 8:00 PM MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossm... Source: Bronstein, Gewirtz & Grossman, Llc Jun 14, 2024 @ 12:00 PM Mineralys Therapeutics Appoints Biopharmaceutical ... Source: Mineralys Therapeutics, Inc. Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.79 $-1.13 Diluted EPS $-.79 $-1.13 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -42.21M $ -56.34M Operating Income / Loss $ $ -44.45M $ -60.11M Cost of Revenue $ $ $ Net Cash Flow $ $ 50.92M $ 29.42M PE Ratio